Administración de Misoprostol rectal para la prevención de hemorragia postparto por atonía uterina en mujeres con factores de riesgo
Fecha
2019-06-13
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Jaén: Universidad de Jaén
Resumen
[ES]Proyecto de ensayo clínico controlado en el que se compara el protocolo de prevención de HPP vigente en el
Hospital Universitario Miguel Servet de Zaragoza con las medidas habituales de prevención que se realizan
en el Hospital de Jaén. El presente estudio está diseñado para que lo único que diferencie las medidas
preventivas realizadas en ambos grupos sea la administración de 600μg de Misoprostol rectal en el grupo de
mujeres de Zaragoza. Se ha estimado la muestra en 1082 mujeres (541+541). Se valorará en ambos grupos
la necesidad o no de aplicación de medidas terapéuticas ante una HPP. En primer lugar, se realizará un
análisis univariante de tipo descriptivo. Posteriormente, se analizará la efectividad del Misoprostol rectal
mediante un análisis Chi-Cuadrado de Pearson.
[EN]A proyect of controlled clinical trial comparing the current PPH prevention protocol at Miguel Servet University Hospital (Zaragoza) and the usual prevention measures carried out at Hospital de Jaén. The present study is designed so that the only difference between the preventive measures carried out by both institutions would be the administration of 600μg of rectal Misoprostol in the group of women at Miguel Servet University Hospital (Zaragoza). The sample was estimated at 1082 women (541+541). In both groups, the need for application of therapeutic measures in the presence of PPH will be assessed. In the first place, an univariate analysis of a descriptive type will be carried out. Subsequently, the effectiveness of rectal Misoprostol will be analyzed through a Chi-Square analysis of Pearson.
[EN]A proyect of controlled clinical trial comparing the current PPH prevention protocol at Miguel Servet University Hospital (Zaragoza) and the usual prevention measures carried out at Hospital de Jaén. The present study is designed so that the only difference between the preventive measures carried out by both institutions would be the administration of 600μg of rectal Misoprostol in the group of women at Miguel Servet University Hospital (Zaragoza). The sample was estimated at 1082 women (541+541). In both groups, the need for application of therapeutic measures in the presence of PPH will be assessed. In the first place, an univariate analysis of a descriptive type will be carried out. Subsequently, the effectiveness of rectal Misoprostol will be analyzed through a Chi-Square analysis of Pearson.